These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31727388)

  • 1. Attempts to downregulate ovarian function in the bitch by applying a GnRH agonist implant in combination with a 3ß-hydroxysteroid-dehydrogenase blocker; a pilot study.
    Jurczak A; Janowski T; Zdunczyk S; Failing K; Schuler G; Hoffmann B
    Theriogenology; 2020 Mar; 145():176-180. PubMed ID: 31727388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH-agonist deslorelin implant alters the progesterone release pattern during early pregnancy in gilts.
    Haen SM; Heinonen M; Kauffold J; Heikinheimo M; Hoving LL; Soede NM; Peltoniemi OAT
    Reprod Domest Anim; 2019 Mar; 54(3):464-472. PubMed ID: 30431675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares.
    Johnson CA; Thompson DL; Cartmill JA
    J Anim Sci; 2003 May; 81(5):1300-7. PubMed ID: 12772858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible estrous cycle suppression in prepubertal female rabbits treated with slow-release deslorelin implants.
    Geyer A; Daub L; Otzdorff C; Reese S; Braun J; Walter B
    Theriogenology; 2016 Jan; 85(2):282-7. PubMed ID: 26489909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient suppression of ovulatory ovarian function in pony mares after treatment with slow-release deslorelin implants.
    Kaps M; Okada CTC; Gautier C; Aurich J; Scarlet D; Kuhl J; Aurich C
    Domest Anim Endocrinol; 2021 Jan; 74():106505. PubMed ID: 32846375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary and testicular endocrine responses to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants.
    Junaidi A; Williamson PE; Martin GB; Stanton PG; Blackberry MA; Cummins JM; Trigg TE
    Reprod Fertil Dev; 2007; 19(8):891-8. PubMed ID: 18076821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary function, ovarian follicular growth, and plasma concentrations of 17 beta-estradiol and progesterone in prepubertal heifers during and after treatment with the luteinizing hormone-releasing hormone agonist deslorelin.
    Bergfeld EG; D'Occhio MJ; Kinder JE
    Biol Reprod; 1996 Apr; 54(4):776-82. PubMed ID: 8924496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an implant containing the GnRH agonist deslorelin on secretion of LH, ovarian activity and milk yield of postpartum dairy cows.
    Mattos R; Orlandi C; Williams J; Staples CR; Trigg T; Thatcher WW
    Theriogenology; 2001 Aug; 56(3):371-86. PubMed ID: 11516118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of exogenous progestin on the occurrence of proestrous or estrous signs, plasma concentrations of luteinizing hormone and estradiol in deslorelin (GnRH agonist) treated anestrous bitches.
    Sung M; Armour AF; Wright PJ
    Theriogenology; 2006 Oct; 66(6-7):1513-7. PubMed ID: 16488001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys.
    Zelinski-Wooten MB; Hess DL; Wolf DP; Stouffer RL
    Fertil Steril; 1994 Jun; 61(6):1147-55. PubMed ID: 8194632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration patterns for luteinising hormone and ovarian function following treatment with GnRH agonist implants (deslorelin) for 7, 14 or 21 days in cycling dairy cows.
    Padula AM; Macmillan KL
    Anim Reprod Sci; 2005 Jun; 87(1-2):11-24. PubMed ID: 15885437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the luteinizing hormone-releasing hormone agonist, deslorelin, on patterns of estradiol-17 beta and luteinizing hormone secretion, ovarian follicular responses to superstimulation with follicle-stimulating hormone, and recovery and in vitro development of oocytes in heifer calves.
    Maclellan LJ; Bergfeld EG; Earl CR; Fitzpatrick LA; Aspden WJ; Kinder JE; Walsh J; Trigg TE; D'Occhio MJ
    Biol Reprod; 1997 Apr; 56(4):878-84. PubMed ID: 9096868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of deslorelin (GnRH agonist) in companion animals: a review.
    Lucas X
    Reprod Domest Anim; 2014 Oct; 49 Suppl 4():64-71. PubMed ID: 25277434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist.
    Fontaine E; Mir F; Vannier F; Gérardin A; Albouy M; Navarro C; Fontbonne A
    Theriogenology; 2011 Nov; 76(8):1561-6. PubMed ID: 21872318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to rhesus monkeys at the midluteal phase of the menstrual cycle: evidence for possible autocrine regulation of the primate corpus luteum by progesterone.
    Duffy DM; Hess DL; Stouffer RL
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1587-94. PubMed ID: 7989460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of buserelin injection and deslorelin (GnRH-agonist) implants on plasma progesterone, LH, accessory CL formation, follicle and corpus luteum dynamics in Holstein cows.
    Rajamahendran R; Ambrose JD; Schmitt EJ; Thatcher MJ; Thatcher WW
    Theriogenology; 1998 Nov; 50(7):1141-55. PubMed ID: 10734431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-pubertal treatment with a GnRH agonist in bitches-Effect on the uterus and hormone receptor expression.
    Schäfer-Somi S; Kaya D; Sözmen M; Kaya S; Aslan S
    Reprod Domest Anim; 2018 Nov; 53 Suppl 3():103-109. PubMed ID: 30474335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.